Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the domain of hematological malignancies. Novel therapies such as targeted therapy, immunotherapies, and gene editing are revolutionizing the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering potential for more curative treat